Trial Profile
The Effect of Gabapentin on Postoperative Pain: a Randomized, Double Blind, Placebo Controlled Trial
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2021
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 21 Sep 2015 Planned End Date changed from 1 Aug 2015 to 1 Aug 2016 as reported by ClinicalTrials.gov record.
- 21 Sep 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 13 Nov 2013 Planned end date changed from 1 Dec 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov.